Smoking-attributable mortality in South America: A systematic review.
Journal
Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780
Informations de publication
Date de publication:
27 Mar 2021
27 Mar 2021
Historique:
entrez:
8
4
2021
pubmed:
9
4
2021
medline:
19
8
2021
Statut:
epublish
Résumé
Dating from the 1920s and linked to the increase in mortality among smokers, tobacco has become one of the most studied health risk factors. Tobacco-use series, whether for the general population or for specific groups, are unavailable for most South American countries, something that hinders the characterisation of this risk factor. To identify and analyse studies that estimate smoking-attributable mortality (SAM) in South America and provide an overview of the impact of smoking habit on mortality in the region. Systematic review using PubMed, Embase, LILACS, The search yielded 140 papers, 17 of which fulfilled the inclusion criteria. There were SAM estimates for all South American countries, with Argentina having the most. The first estimate covered 1981 and the latest, 2013. The method most used was prevalence-based. Regardless of the country and point in time covered by the estimate, the highest figures were recorded for men in all cases. The burden of attributable vs observed mortality varied among countries, reaching a figure of 20.3% in Argentina in 1986. The highest SAM burden was registered for the group of cardiovascular diseases. SAM estimates are available for all South American countries but the respective study periods differ and the frequency of the estimates is unclear. For 4 countries, the only estimates available are drawn from reports, something that does not allow for a detailed assessment of the estimates obtained. To help with decision-making targeted at evaluating and enhancing the impact of smoking control policies, further studies are needed in order to update the impact of smoking on all countries across South America.
Sections du résumé
BACKGROUND
BACKGROUND
Dating from the 1920s and linked to the increase in mortality among smokers, tobacco has become one of the most studied health risk factors. Tobacco-use series, whether for the general population or for specific groups, are unavailable for most South American countries, something that hinders the characterisation of this risk factor.
OBJECTIVES
OBJECTIVE
To identify and analyse studies that estimate smoking-attributable mortality (SAM) in South America and provide an overview of the impact of smoking habit on mortality in the region.
METHODS
METHODS
Systematic review using PubMed, Embase, LILACS,
RESULTS
RESULTS
The search yielded 140 papers, 17 of which fulfilled the inclusion criteria. There were SAM estimates for all South American countries, with Argentina having the most. The first estimate covered 1981 and the latest, 2013. The method most used was prevalence-based. Regardless of the country and point in time covered by the estimate, the highest figures were recorded for men in all cases. The burden of attributable vs observed mortality varied among countries, reaching a figure of 20.3% in Argentina in 1986. The highest SAM burden was registered for the group of cardiovascular diseases.
CONCLUSIONS
CONCLUSIONS
SAM estimates are available for all South American countries but the respective study periods differ and the frequency of the estimates is unclear. For 4 countries, the only estimates available are drawn from reports, something that does not allow for a detailed assessment of the estimates obtained. To help with decision-making targeted at evaluating and enhancing the impact of smoking control policies, further studies are needed in order to update the impact of smoking on all countries across South America.
Identifiants
pubmed: 33828844
doi: 10.7189/jogh.11.04014
pii: jogh-11-04014
pmc: PMC8005314
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
04014Informations de copyright
Copyright © 2021 by the Journal of Global Health. All rights reserved.
Déclaration de conflit d'intérêts
Competing interests: The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author), and declare no conflicts of interest.
Références
BMC Public Health. 2008 Jan 22;8:22
pubmed: 18211696
Am J Public Health. 2015 Jun;105(6):1246-53
pubmed: 25880938
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Salud Publica Mex. 2017;59Suppl 1(Suppl 1):117-125
pubmed: 28658460
Arch Bronconeumol. 2020 Sep;56(9):559-563
pubmed: 35373765
Lancet. 2017 May 13;389(10082):1885-1906
pubmed: 28390697
N Engl J Med. 2013 Jan 24;368(4):351-64
pubmed: 23343064
Popul Health Metr. 2014 May 14;12:14
pubmed: 24982595
Bol Oficina Sanit Panam. 1991 Aug;111(2):112-21
pubmed: 1834082
BMC Public Health. 2009 Jun 26;9:206
pubmed: 19558658
BMJ. 2019 Jan 28;364:l251
pubmed: 30692093
BMC Med. 2020 Mar 9;18(1):58
pubmed: 32146906
Medicina (B Aires). 2016;76(5):287-293
pubmed: 27723616
Br Med Bull. 1996 Jan;52(1):12-21
pubmed: 8746293
Bull World Health Organ. 2005 Oct;83(10):799-800
pubmed: 16283059